Mundisal (Choline Salicylate)

Choline salicylate inhibits cyclooxygenase enzymes, reducing the formation of prostaglandins that cause pain and swelling. By limiting prostaglandin production at the site of application, the product provides localized analgesic and anti‑inflammatory activity without significant systemic exposure.

The appropriate dose of Mundisal is determined by the prescribing healthcare professional based on the patient’s age, condition and route of administration. Patients should follow the prescriber’s instructions and the product label for the correct amount and frequency.

Safety data for choline salicylate in pregnancy and lactation are limited. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Mundisal.

To order Mundisal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mundisal delivers choline salicylate in a formulation designed for nasal, oromucosal and oropharyngeal use, offering rapid local relief. Compared with oral aspirin or other systemic salicylates, Mundisal provides targeted action with lower systemic exposure, which may reduce the risk of gastrointestinal side effects.

Mundisal should be stored at ambient temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture and direct sunlight, and store it in its original packaging to maintain product stability.

Mundisal is applied directly to the affected area using the supplied applicator. For nasal use, a few sprays are delivered into each nostril; for oral or throat discomfort, the solution is sprayed onto the mucosa as directed by the prescriber.

Serious risks include allergic reactions such as rash, angioedema, or Stevens‑Johnson syndrome, and rare but severe gastrointestinal bleeding. Patients with a history of hypersensitivity to salicylates should avoid the product and seek immediate medical attention if serious symptoms develop.

Mundisal should not be used by individuals with known hypersensitivity to salicylates, those with active bleeding disorders, or patients taking anticoagulant therapy without medical supervision. It is also contraindicated in patients with severe asthma triggered by aspirin or other NSAIDs.